Home › Stomach Cancer
Stomach Cancer clinical trials recruiting in the U.S.
134 studies for Stomach Cancer are recruiting participants at sites across the United States.
Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.
Cities with the most studies
- Houston, TX42 studies
- Boston, MA32 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA22 studies
- Baldwin Park, CA22 studies
- Arlington, VA20 studies
- Dallas, TX19 studies
- San Antonio, TX19 studies
- Grand Rapids, MI18 studies
- St. Louis, MO18 studies
- Washington, DC16 studies
- Detroit, MI16 studies
- Chicago, IL16 studies
- Philadelphia, PA15 studies
- Atlanta, GA14 studies
- Pittsburgh, PA14 studies
- Portland, OR13 studies
- Orange, CA13 studies
- Denver, CO12 studies
- Cleveland, OH12 studies
- Mountain View, CA12 studies
- Madison, WI11 studies
- Orlando, FL10 studies
- Austin, TX10 studies
- Aurora, CO10 studies
- Seattle, WA10 studies
- Queens, NY10 studies
- Durham, NC10 studies
- Oklahoma City, OK10 studies
- Edison, NJ9 studies
- Phoenix, AZ9 studies
- Tampa, FL9 studies
- Columbus, OH9 studies
- San Diego, CA9 studies
- Omaha, NE9 studies
- Kansas City, MO9 studies
- Santa Monica, CA9 studies
- Rochester, MN9 studies
- Minneapolis, MN9 studies
By state
- Alabama6 studies
- Alaska4 studies
- Arizona13 studies
- Arkansas6 studies
- California69 studies
- Colorado23 studies
- Connecticut10 studies
- Delaware4 studies
- District of Columbia4 studies
- Florida38 studies
- Georgia16 studies
- Idaho3 studies
- Illinois19 studies
- Indiana10 studies
- Iowa8 studies
- Kansas8 studies
- Kentucky9 studies
- Louisiana5 studies
- Maine3 studies
- Maryland20 studies
- Massachusetts34 studies
- Michigan35 studies
- Minnesota18 studies
- Missouri23 studies
- Montana4 studies
- Nebraska9 studies
- Nevada5 studies
- New Jersey12 studies
- New Mexico5 studies
- New York38 studies
- North Carolina21 studies
- North Dakota4 studies
- Ohio24 studies
- Oklahoma11 studies
- Oregon14 studies
- Pennsylvania30 studies
- Rhode Island5 studies
- South Carolina9 studies
- South Dakota4 studies
- Tennessee30 studies
- Texas60 studies
- Utah14 studies
- Virginia27 studies
- Washington14 studies
- West Virginia4 studies
- Wisconsin18 studies
Recently updated studies
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Oct 2, 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT06885697Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07529808Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
RecruitingObservational study
Ages 6 and older · All sexes · Updated Oct 2, 2026 · NCT04557969Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06586957Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RecruitingObservational study
Ages 2 and older · All sexes · Updated Oct 1, 2026 · NCT01915225A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07221149AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06219941A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07814248Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07700979Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07360314A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07578571IKS014 in Advanced Solid Tumors That Express HER2
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05872295Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07392892Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06005493Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07069712Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT05523947Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RecruitingPhase 2
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT05489211A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07631000From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.